Inflammation Focus Oral Genomics specializes in inflammatory and genetic testing related to oral health, positioning them to cross-sell to healthcare entities dealing with systemic inflammatory conditions such as cardiovascular disease, diabetes, and dementia.

Small Team agility With a lean team of 2-10 employees, there is potential for high-touch partnerships, white-label or co-development agreements, and rapid pilot programs with larger distributors or healthcare networks seeking innovative oral care solutions.

B2B Partnerships Existing emphasis on partnering with biomedical and healthcare entities suggests opportunities to expand via collaborations with clinics, hospitals, research institutions, and dental networks seeking customized systems and treatment protocols.

Growth Potential Revenue is under $1M, indicating substantial upside for channel sales, strategic alliances, and premium-genetic testing offerings to capture a larger share of the dental and medical markets focused on inflammation-linked risks.

Tech Stack Fit Current tools (Microsoft 365, Google Search Console, GoDaddy) imply readiness for scalable digital marketing, CRM integration, and online lead generation to support outbound selling and partner recruitment.